<DOC>
	<DOC>NCT00453401</DOC>
	<brief_summary>Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.</brief_summary>
	<brief_title>Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>5- ((2- (6- Amino- 9H- purin- 9- yl) ethyl) amino) - 1- pentanol</mesh_term>
	<criteria>18 to 80 years of age of either gender Good general health History of recurrent herpes labialis with at least 3 episodes per year Pregnant and/or nursing female Lesions or irritation on or around the lips that would interfere with recognition of a herpes labialis attack Treatment with topical steroids, antivirals, or new topical products on or around the lips in the week prior to the onset of an attack Known allergies to topical creams, ointments or medications. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>cold sore</keyword>
</DOC>